Global Interventional Oncology Ablation Device Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11244633

Publication Date:

December 2, 2024

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Interventional Oncology Ablation Device market size was valued at US$ 538 million in 2023. With growing demand in downstream market, the Interventional Oncology Ablation Device is forecast to a readjusted size of US$ 972.1 million by 2030 with a CAGR of 8.8% during review period.
The research report highlights the growth potential of the global Interventional Oncology Ablation Device market. Interventional Oncology Ablation Device are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Interventional Oncology Ablation Device. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Interventional Oncology Ablation Device market.
Tumor Ablation is a general term for destroying cancer cells. Interventional ablation is a targeted, image-guided therapy for liver, kidney and lung cancers that uses the direct application of extreme heat (radiofrequency and microwave) or cold (cryoablation) to destroy tumor cells. It is most appropriate for small kidney and liver cancers that cannot be removed surgically. In fact, radiofrequency and cryoablation of small kidney cancers have been shown to be just as effective as major surgery.
Increasing product approvals by regulatory authorities is expected to propel the growth of the global interventional oncology ablation market over the forecast period.
Key Features:
The report on Interventional Oncology Ablation Device market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Interventional Oncology Ablation Device market. It may include historical data, market segmentation by Type (e.g., Radiofrequency Ablation, Microwave Ablation), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Interventional Oncology Ablation Device market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Interventional Oncology Ablation Device market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Interventional Oncology Ablation Device industry. This include advancements in Interventional Oncology Ablation Device technology, Interventional Oncology Ablation Device new entrants, Interventional Oncology Ablation Device new investment, and other innovations that are shaping the future of Interventional Oncology Ablation Device.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Interventional Oncology Ablation Device market. It includes factors influencing customer ' purchasing decisions, preferences for Interventional Oncology Ablation Device product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Interventional Oncology Ablation Device market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Interventional Oncology Ablation Device market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Interventional Oncology Ablation Device market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Interventional Oncology Ablation Device industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Interventional Oncology Ablation Device market.
Market Segmentation:
Interventional Oncology Ablation Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Other
Segmentation by application
Liver Cancer
Lung Cancer
Kidney Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Medtronic
Johnson & Johnson
Merit Medical
Varian Medical
AngioDynamics
HealthTronics
EDAP TMS
SonaCare Medical
Misonix
CAScination AG
Biomedical Srl
Chongqing Haifu Medical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional Oncology Ablation Device Market Size 2019-2030
2.1.2 Interventional Oncology Ablation Device Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Interventional Oncology Ablation Device Segment by Type
2.2.1 Radiofrequency Ablation
2.2.2 Microwave Ablation
2.2.3 Cryoablation
2.2.4 Other
2.3 Interventional Oncology Ablation Device Market Size by Type
2.3.1 Interventional Oncology Ablation Device Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Interventional Oncology Ablation Device Market Size Market Share by Type (2019-2024)
2.4 Interventional Oncology Ablation Device Segment by Application
2.4.1 Liver Cancer
2.4.2 Lung Cancer
2.4.3 Kidney Cancer
2.4.4 Others
2.5 Interventional Oncology Ablation Device Market Size by Application
2.5.1 Interventional Oncology Ablation Device Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Interventional Oncology Ablation Device Market Size Market Share by Application (2019-2024)
3 Interventional Oncology Ablation Device Market Size by Player
3.1 Interventional Oncology Ablation Device Market Size Market Share by Players
3.1.1 Global Interventional Oncology Ablation Device Revenue by Players (2019-2024)
3.1.2 Global Interventional Oncology Ablation Device Revenue Market Share by Players (2019-2024)
3.2 Global Interventional Oncology Ablation Device Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Interventional Oncology Ablation Device by Regions
4.1 Interventional Oncology Ablation Device Market Size by Regions (2019-2024)
4.2 Americas Interventional Oncology Ablation Device Market Size Growth (2019-2024)
4.3 APAC Interventional Oncology Ablation Device Market Size Growth (2019-2024)
4.4 Europe Interventional Oncology Ablation Device Market Size Growth (2019-2024)
4.5 Middle East & Africa Interventional Oncology Ablation Device Market Size Growth (2019-2024)
5 Americas
5.1 Americas Interventional Oncology Ablation Device Market Size by Country (2019-2024)
5.2 Americas Interventional Oncology Ablation Device Market Size by Type (2019-2024)
5.3 Americas Interventional Oncology Ablation Device Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Oncology Ablation Device Market Size by Region (2019-2024)
6.2 APAC Interventional Oncology Ablation Device Market Size by Type (2019-2024)
6.3 APAC Interventional Oncology Ablation Device Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Interventional Oncology Ablation Device by Country (2019-2024)
7.2 Europe Interventional Oncology Ablation Device Market Size by Type (2019-2024)
7.3 Europe Interventional Oncology Ablation Device Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Interventional Oncology Ablation Device by Region (2019-2024)
8.2 Middle East & Africa Interventional Oncology Ablation Device Market Size by Type (2019-2024)
8.3 Middle East & Africa Interventional Oncology Ablation Device Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Interventional Oncology Ablation Device Market Forecast
10.1 Global Interventional Oncology Ablation Device Forecast by Regions (2025-2030)
10.1.1 Global Interventional Oncology Ablation Device Forecast by Regions (2025-2030)
10.1.2 Americas Interventional Oncology Ablation Device Forecast
10.1.3 APAC Interventional Oncology Ablation Device Forecast
10.1.4 Europe Interventional Oncology Ablation Device Forecast
10.1.5 Middle East & Africa Interventional Oncology Ablation Device Forecast
10.2 Americas Interventional Oncology Ablation Device Forecast by Country (2025-2030)
10.2.1 United States Interventional Oncology Ablation Device Market Forecast
10.2.2 Canada Interventional Oncology Ablation Device Market Forecast
10.2.3 Mexico Interventional Oncology Ablation Device Market Forecast
10.2.4 Brazil Interventional Oncology Ablation Device Market Forecast
10.3 APAC Interventional Oncology Ablation Device Forecast by Region (2025-2030)
10.3.1 China Interventional Oncology Ablation Device Market Forecast
10.3.2 Japan Interventional Oncology Ablation Device Market Forecast
10.3.3 Korea Interventional Oncology Ablation Device Market Forecast
10.3.4 Southeast Asia Interventional Oncology Ablation Device Market Forecast
10.3.5 India Interventional Oncology Ablation Device Market Forecast
10.3.6 Australia Interventional Oncology Ablation Device Market Forecast
10.4 Europe Interventional Oncology Ablation Device Forecast by Country (2025-2030)
10.4.1 Germany Interventional Oncology Ablation Device Market Forecast
10.4.2 France Interventional Oncology Ablation Device Market Forecast
10.4.3 UK Interventional Oncology Ablation Device Market Forecast
10.4.4 Italy Interventional Oncology Ablation Device Market Forecast
10.4.5 Russia Interventional Oncology Ablation Device Market Forecast
10.5 Middle East & Africa Interventional Oncology Ablation Device Forecast by Region (2025-2030)
10.5.1 Egypt Interventional Oncology Ablation Device Market Forecast
10.5.2 South Africa Interventional Oncology Ablation Device Market Forecast
10.5.3 Israel Interventional Oncology Ablation Device Market Forecast
10.5.4 Turkey Interventional Oncology Ablation Device Market Forecast
10.5.5 GCC Countries Interventional Oncology Ablation Device Market Forecast
10.6 Global Interventional Oncology Ablation Device Forecast by Type (2025-2030)
10.7 Global Interventional Oncology Ablation Device Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Boston Scientific
11.1.1 Boston Scientific Company Information
11.1.2 Boston Scientific Interventional Oncology Ablation Device Product Offered
11.1.3 Boston Scientific Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Boston Scientific Main Business Overview
11.1.5 Boston Scientific Latest Developments
11.2 Medtronic
11.2.1 Medtronic Company Information
11.2.2 Medtronic Interventional Oncology Ablation Device Product Offered
11.2.3 Medtronic Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Medtronic Main Business Overview
11.2.5 Medtronic Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Interventional Oncology Ablation Device Product Offered
11.3.3 Johnson & Johnson Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Merit Medical
11.4.1 Merit Medical Company Information
11.4.2 Merit Medical Interventional Oncology Ablation Device Product Offered
11.4.3 Merit Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merit Medical Main Business Overview
11.4.5 Merit Medical Latest Developments
11.5 Varian Medical
11.5.1 Varian Medical Company Information
11.5.2 Varian Medical Interventional Oncology Ablation Device Product Offered
11.5.3 Varian Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Varian Medical Main Business Overview
11.5.5 Varian Medical Latest Developments
11.6 AngioDynamics
11.6.1 AngioDynamics Company Information
11.6.2 AngioDynamics Interventional Oncology Ablation Device Product Offered
11.6.3 AngioDynamics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AngioDynamics Main Business Overview
11.6.5 AngioDynamics Latest Developments
11.7 HealthTronics
11.7.1 HealthTronics Company Information
11.7.2 HealthTronics Interventional Oncology Ablation Device Product Offered
11.7.3 HealthTronics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 HealthTronics Main Business Overview
11.7.5 HealthTronics Latest Developments
11.8 EDAP TMS
11.8.1 EDAP TMS Company Information
11.8.2 EDAP TMS Interventional Oncology Ablation Device Product Offered
11.8.3 EDAP TMS Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 EDAP TMS Main Business Overview
11.8.5 EDAP TMS Latest Developments
11.9 SonaCare Medical
11.9.1 SonaCare Medical Company Information
11.9.2 SonaCare Medical Interventional Oncology Ablation Device Product Offered
11.9.3 SonaCare Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 SonaCare Medical Main Business Overview
11.9.5 SonaCare Medical Latest Developments
11.10 Misonix
11.10.1 Misonix Company Information
11.10.2 Misonix Interventional Oncology Ablation Device Product Offered
11.10.3 Misonix Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Misonix Main Business Overview
11.10.5 Misonix Latest Developments
11.11 CAScination AG
11.11.1 CAScination AG Company Information
11.11.2 CAScination AG Interventional Oncology Ablation Device Product Offered
11.11.3 CAScination AG Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 CAScination AG Main Business Overview
11.11.5 CAScination AG Latest Developments
11.12 Biomedical Srl
11.12.1 Biomedical Srl Company Information
11.12.2 Biomedical Srl Interventional Oncology Ablation Device Product Offered
11.12.3 Biomedical Srl Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Biomedical Srl Main Business Overview
11.12.5 Biomedical Srl Latest Developments
11.13 Chongqing Haifu Medical
11.13.1 Chongqing Haifu Medical Company Information
11.13.2 Chongqing Haifu Medical Interventional Oncology Ablation Device Product Offered
11.13.3 Chongqing Haifu Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Chongqing Haifu Medical Main Business Overview
11.13.5 Chongqing Haifu Medical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂